More articles from 5.1 Airway Pharmacology and Treatment

Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Emanuel Citgez, Job van der Palen, Paul van der Valk, Kirsten Koehorst-ter Huurne, Kris Movig, Marjolein Brusse-Keizer

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4066; DOI: 10.1183/13993003.congress-2016.PA4066
Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients
Mathieu Molimard, C. Raherison, S. Lamarque, S. Lignot-Maleyran, A. Balestra, A. Chartier, R. Lassalle, C. Droz-Perroteau, P.O. Girodet

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4078; DOI: 10.1183/13993003.congress-2016.PA4078
Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome
Elena Blinova, Galina Ignatova, Maria Belsner

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4068; DOI: 10.1183/13993003.congress-2016.PA4068
Effect of borago extract on moderate persistent asthma, a phase two randomized, double blind placebo-controlled clinical trial
Majid Mirsadraee, Sara Khashkhashi Moghaddam, Parisa Saeidi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4116; DOI: 10.1183/13993003.congress-2016.PA4116
Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Khalil Ansarin, Payam Salehirad, Mohammadamin Rezazadehsaatlou

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4053; DOI: 10.1183/13993003.congress-2016.PA4053
Compare clinical effectiveness of various types of bronchodilators in COPD patients
Tatiana Germanovna Shapovalova, Nina Andreevna Ivaniva, Elena Evgenyevna Arhangelskaya, Elena Sergeevna Plastinina, Natalia Vladimirovna Shelobanova, Olga Aleksandrovna Ponomareva, Marina Viktorovna Margasova, Anna Yrievna Ryabova, Marina Mikhailovna Shashina

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4046; DOI: 10.1183/13993003.congress-2016.PA4046
Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study
Konstantinos Kostikas, Claus Vogelmeier, Timm Greulich, Jose M. Marin, Walter Castellani, Thomas Similowski, Vincent Ninane, Mina Gaga, Stephen Lane, Maryam Aalamian-Mattheis, Xavier Nunez, Andreas Clemens

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4056; DOI: 10.1183/13993003.congress-2016.PA4056
LATE-BREAKING ABSTRACT: Safety, pharmacokinetics and pharmacodynamics of BI 1060469, a novel oral CRTH2 antagonist
Eric Bateman, Alison Mackie, Ewald Benediktus, Carnelia Schepers, Jiyeong Maria Kim, Yusuke Tadayasu, Ganghyuck Lee, Chester Wood, Benjamin Weber

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4125; DOI: 10.1183/13993003.congress-2016.PA4125
Patient characteristics of new initiators of glycopyrronium bromide (GLY) – A multinational, multi-database real-world drug-utilization study
Katia M.C. Verhamme, Maria De Ridder, Lars Pedersen, Daniel Prieto-Alhambra, Francesco Lapi, Peter Rijnbeek, Rajeev K. Amar, Miriam Sturkenboom

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4063; DOI: 10.1183/13993003.congress-2016.PA4063
Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells
Chuen-Mao Yang

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4093; DOI: 10.1183/13993003.congress-2016.PA4093

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us